Internal Medicine, Nephrology · New Orleans, LA
NPI
1174565758
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1514 Jefferson Hwy
New Orleans, LA, 70121
Phone (504) 842-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
182 services
Medicare patients, 2024
78
Average age 58
Drug cost, 2024
$187K
1,131 prescriptions
Company payments, 2023
$756
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Catherine G Staffeld Coit was code 99233 (hospital e&m - subsequent), 74 times for 31 patients. In total Catherine G Staffeld Coit billed 182 services in 12 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 74 | 31 | $78.71 | $5,825 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 16 | $58.10 | $1,569 |
| 99215 Office E&M - Established | Office | 17 | 11 | $115.38 | $1,961 |
| 99215 Office E&M - Established | Facility | 14 | 14 | $100.01 | $1,400 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $122.14 | $1,588 |
By year: 2022 $27K for 326 services; 2023 $25K for 275 services; 2024 $14K for 182 services.
Medicare prescription drug claims, 2024
In 2024, the drug Catherine G Staffeld Coit prescribed most often to Medicare patients was Prednisone, with 115 prescriptions and refills. In total Catherine G Staffeld Coit wrote 1,131 Medicare prescriptions that cost $187K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 115 | 188 | 40 | $579 |
| Nifedipine Er Nifedipine | 82 | 112 | 27 | $1,629 |
| Carvedilol Generic | 69 | 114 | 20 | $289 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 55 | 61 | 23 | $254 |
| Valganciclovir Hcl Generic | 53 | 60 | 30 | $6,131 |
| Cinacalcet Hcl Generic | 52 | 82 | 12 | $9,713 |
| Ketoconazole Generic | 48 | 58 | 11 | $679 |
| Nulojix Belatacept | 44 | 44 | Under 11 | $88K |
| Calcitriol Generic | 40 | 58 | Under 11 | $669 |
| Tacrolimus Generic | 39 | 39 | Under 11 | $3,196 |
| Mycophenolic Acid Mycophenolate Sodium | 32 | 32 | Under 11 | $6,861 |
| Dapsone Generic | 30 | 36 | Under 11 | $1,286 |
| Famotidine Generic | 27 | 43 | 20 | $207 |
| Atovaquone Generic | 23 | 23 | Under 11 | $8,794 |
| Amlodipine Besylate Generic | 23 | 41 | Under 11 | $137 |
Brand drugs: 156 claims; generic drugs: 952 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Catherine G Staffeld Coit $756 ($756 in general payments such as food, travel and fees) from 7 companies. The largest payer was Veloxis Pharmaceuticals, Inc. with $151.
| Company | Payments | Amount |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 2 | $151 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Mallinckrodt Hospital Products Inc. | 1 | $125 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $101 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $98.8 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $29.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.